Article
Molecular Cancer Therapeutics  (2015)

Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications

Adelaiye, R.; Ciamporcero, E.; Miles, K. M.; Bard, J.; Tsompana, M.; Conroy, D.; Orillion, A; Prey, J.; Fetterly, G.; Chintala, S.; Bjarnason, G. A.